Bio Solution Co.,Ltd. (KOSDAQ: 086820)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,830
+550 (2.85%)
Dec 20, 2024, 12:51 PM KST

Bio Solution Co.,Ltd. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2020 FY 2019
Period Ending
Mar '21 Dec '20 Dec '19
Net Income
-1,283-1,800-697.54
Depreciation & Amortization
1,8331,8001,536
Loss (Gain) From Sale of Investments
-65.77-103.52-347.5
Stock-Based Compensation
39.4729.77-
Provision & Write-off of Bad Debts
-7.77-6.99-41.85
Other Operating Activities
287.63404.27206.46
Change in Accounts Receivable
169.89696.67-633.85
Change in Inventory
-364.05-907.88151.05
Change in Accounts Payable
-86.2696.44-127.37
Change in Other Net Operating Assets
-1,431-1,896-2,652
Operating Cash Flow
-912.77-1,686-2,606
Capital Expenditures
-747.23-1,391-2,179
Sale (Purchase) of Intangibles
-1,020-1,114-298.84
Investment in Securities
5,4626,2623,453
Other Investing Activities
7.3-0.18-179.02
Investing Cash Flow
3,7033,756795.88
Long-Term Debt Repaid
--792.65-667.56
Net Debt Issued (Repaid)
-985.92-792.65-667.56
Issuance of Common Stock
508.5508.51,211
Other Financing Activities
-191.72112.14-1.2
Financing Cash Flow
-669.14-172.02541.74
Foreign Exchange Rate Adjustments
-3.38-15.134.03
Miscellaneous Cash Flow Adjustments
00-
Net Cash Flow
2,1171,883-1,264
Free Cash Flow
-1,660-3,077-4,785
Free Cash Flow Margin
-20.06%-39.73%-53.87%
Free Cash Flow Per Share
-208.22-386.38-608.62
Cash Interest Paid
52.9737.5150.16
Cash Income Tax Paid
151.94120.85112.78
Levered Free Cash Flow
--3,942-
Unlevered Free Cash Flow
--3,917-
Change in Net Working Capital
-1,131-
Source: S&P Capital IQ. Standard template. Financial Sources.